Browse > Article
http://dx.doi.org/10.3345/kjp.2014.57.3.153

Toxic epidermal necrolysis induced by lamotrigine treatment in a child  

Yi, Youngsuk (Department of Pediatrics, Soonchunhyang University Hospital, Soonchunhyang University College of Medicine)
Lee, Jeong Ho (Department of Pediatrics, Soonchunhyang University Hospital, Soonchunhyang University College of Medicine)
Suh, Eun Sook (Department of Pediatrics, Soonchunhyang University Hospital, Soonchunhyang University College of Medicine)
Publication Information
Clinical and Experimental Pediatrics / v.57, no.3, 2014 , pp. 153-156 More about this Journal
Abstract
Toxic epidermal necrolysis is an unpredictable and severe adverse drug reaction. In toxic epidermal necrolysis, epidermal damage appears to result from keratinocyte apoptosis. This condition is triggered by many factors, principally drugs such as antiepileptic medications, antibiotics (particularly sulfonamide), nonsteroidal anti-inflammatory drugs, allopurinol, and nevirapine. Lamotrigine has been reported potentially cause serious cutaneous reactions, and concomitant use of valproic acid with lamotrigine significantly increases this risk. We describe a case of an 11-year-old girl with tic and major depressive disorders who developed toxic epidermal necrolysis after treatment with lamotrigine, and who was diagnosed both clinically and pathologically. Children are more susceptible to lamotrigine-induced rash than adults, and risk of serious rash can be lessened by strict adherence to dosing guidelines. Unfortunately, in our case, the patient was administered a higher dose than the required regimen. Therefore, clinicians should strictly adhere to the dose regimen when using lamotrigine, especially in children.
Keywords
Toxic epidermal necrolysis; Adverse drug reaction; Lamotrigine; Antiepileptic drug;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Pereira FA, Mudgil AV, Rosmarin DM. Toxic epidermal necrolysis. J Am Acad Dermatol 2007;56:181-200.   DOI   ScienceOn
2 Downey A, Jackson C, Harun N, Cooper A. Toxic epidermal necrolysis: review of pathogenesis and management. J Am Acad Dermatol 2012;66:995-1003.   DOI   ScienceOn
3 Harr T, French LE. Stevens-Johnson syndrome and toxic epidermal necrolysis. Chem Immunol Allergy 2012;97:149-66.   DOI   ScienceOn
4 Kim DW, Jung DE, Koo JW. Steroid and enalapril therapy-possible cause of toxic epidermal necrolysis. Korean J Pediatr 2006;49:332-6.   DOI
5 Chang CC, Shiah IS, Chang HA, Huang SY. Toxic epidermal necrolysis with combination lamotrigine and valproate in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:147-50.   DOI   ScienceOn
6 Hirsch LJ, Weintraub DB, Buchsbaum R, Spencer HT, Straka T, Hager M, et al. Predictors of Lamotrigine-associated rash. Epilepsia 2006;47:318-22.   DOI   ScienceOn
7 Harr T, French LE. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet J Rare Dis 2010;5:39.   DOI   ScienceOn
8 Joseph G. Morelli. Vesiculobullous disorders. In: Kliegman RM, Stanton BF, St. Geme JW III, Schor NF, Behrman RE, editors. Nelsn textbook of pediatrics. 19th ed. Philadelphia: Elsevier Saunders, 2011:2243.
9 Abood GJ, Nickoloff BJ, Gamelli RL. Treatment strategies in toxic epidermal necrolysis syndrome: where are we at? J Burn Care Res 2008;29:269-76.   DOI
10 Gerull R, Nelle M, Schaible T. Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review. Crit Care Med 2011;39:1521-32.   DOI   ScienceOn
11 Warnock JK, Morris DW. Adverse cutaneous reactions to mood stabilizers. Am J Clin Dermatol 2003;4:21-30.   DOI   ScienceOn
12 Kim KJ, Lee DP, Suh HS, Lee MW, Choi JH, Moon KC, et al. Toxic epidermal necrolysis: analysis of clinical course and SCORTENbased comparison of mortality rate and treatment modalities in Korean patients. Acta Derm Venereol 2005;85:497-502.
13 Lissia M, Mulas P, Bulla A, Rubino C. Toxic epidermal necrolysis (Lyell's disease). Burns 2010;36:152-63.   DOI   ScienceOn
14 Ruetter A, Luger TA. Efficacy and safety of intravenous immunoglobulin for immune-mediated skin disease: current view. Am J Clin Dermatol 2004;5:153-60.   DOI   ScienceOn
15 Li LM, Russo M, O'Donoghue MF, Duncan JS, Sander JW. Allergic skin rash with lamotrigine and concomitant valproate therapy: evidence for an increased risk. Arq Neuropsiquiatr 1996;54:47-9.   DOI
16 Schlienger RG, Shapiro LE, Shear NH. Lamotrigine-induced severe cutaneous adverse reactions. Epilepsia 1998;39 Suppl 7:S22-6.   DOI   ScienceOn
17 Guberman AH, Besag FM, Brodie MJ, Dooley JM, Duchowny MS, Pellock JM, et al. Lamotrigine-associated rash: risk/benefit considerations in adults and children. Epilepsia 1999;40:985-91.   DOI   ScienceOn